Venus Remedies Ltd share price is currently ₹1,627.98, down by - ₹36.95 (2.22%) from its previous closing price of ₹1,664.93. The share price has gained 4.61% over the past month and gained 193.33% over the past year. The stock's 52-week low and high are ₹419.00 and ₹2,014.72, respectively. Venus Remedies Ltd has a market capitalisation of ₹ 2,320.00 Cr. The share price was last updated on 25 Aug 2026, 03:57 PM IST.

Updated: 25 Aug 2026, 03:57:46 pm IST

Mutual Fund Ownership will be available shortly.Venus Remedies Limited is a research-driven pharmaceutical company. The Company is a global injectable manufacturer. It manufactures products catering to critical care segments such as antimicrobial resistance, anti-cancer, Anti-infective, Neurology, Skin and Wound Care, and Pain Management. With a diverse portfolio of products, the Company is dedicated to revolutionizing patient care through its specialized therapeutic segments such as anti-infective (antibiotics), oncology, neurology, pain management, and skin & wound care. The Company operates only in one business segment: Pharmaceutical Formulation and is engaged in manufacturing and trading of medicines. Its focus therapy areas include medicine, surgery, neuro and orthopedics. The Company's brands include Potentox, Vancoplus Combi, Tobracef, Supime, Zydotum, Neurotol, Trois, Septiloc, Mucomelt, and others. It has three manufacturing facilities: Panchkula and Baddi in India and Werne in Germany.

Today's market leaders and laggards
Genesys International Corporation Ltd
GENESYS
₹212.29
+37.16 (21.22%)
Fertilisers And Chemicals Travancore Ltd
FACT
₹862.94
+85.12 (10.94%)
Sigachi Industries Ltd
SIGACHI
₹33.29
+3.26 (10.86%)
Genus Paper & Boards Ltd
GENUSPAPER
₹12.00
+1.12 (10.29%)
Federal-Mogul Goetze (India) Ltd
FMGOETZE
₹529.51
+49.23 (10.25%)